Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [99mTc] Tc-Labeled Small Peptide

医学 乳腺癌 乳腺闪烁照相术 剂量学 药代动力学 核医学 分子成像 癌症 伽玛照相机 内科学 乳腺摄影术 体内 生物 生物技术
作者
Javad Biabani Ardakani,Seyed Mohammad Abedi,Alireza Mardanshahi,Leyla Shojaee,Ehsan Zaboli,Alireza Khorramimoghaddam,Anahita Nosrati,Hamideh Sabahno,Elahm Sadat Banimostafavi,Seyed Jalal Hosseinimehr
出处
期刊:Clinical Breast Cancer [Elsevier BV]
卷期号:23 (2): 219-230 被引量:6
标识
DOI:10.1016/j.clbc.2022.12.002
摘要

The accurate determination of human epidermal growth factor receptor 2 (HER2) status can predict response to treatment with HER2-targeted therapy for HER2-positive breast cancer patients. [99mTc]Tc-HYNIC-(Ser)3-LTVPWY ([99mTc]Tc-HYNIC-LY) is a small synthetic peptide molecule targeting of the HER2 receptor. This clinical study evaluated the pharmacokinetic, dosimetry, and efficacy of [99mTc]Tc-HYNIC-LY for determining the HER2 status in primary breast cancer patients.In total, 24 women with suspected primary breast cancer received an intravenous injection of approximately 20 µg (∼740 MBq) of [99mTc]Tc-HYNIC-LY. In the first 3 patients, blood levels of radioactivity were analyzed for pharmacokinetic evaluation and planar gamma camera imaging was conducted at 30 min and 1, 2, 4, and 24 hour after injection for dosimetry assessment. In the last 21 patients, planar imaging was performed at the baseline, as well as 1, 2, 3, and 4 hour, followed by single-photon emission computed tomography (SPECT) imaging after 4 hour to evaluate the tumor-targeting potential in primary lesions.Injection of [99mTc]Tc-HYNIC-LY was safe and well tolerated. Fast blood clearance provided high-contrast HER2 imaging within 1 to 4 hour. The highest absorbed radiation dose was found for kidneys (6.78E-03 ± 2.62E-04 mSv/MBq), followed by the heart (3.73E-03 ± 1.98E-04 mSv/MBq). The [99mTc]Tc-HYNIC-LY peptide was able to detect HER2 status in primary tumors at an acceptable level.The findings of this study indicated that [99mTc]Tc-HYNIC-LY SPECT is safe and feasible for the identification of HER2-positive lesions in primary breast cancer patients, and may provide an accurate and non-invasive modality for guiding HER2 targeted therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
金水完成签到,获得积分10
刚刚
失眠的血茗完成签到,获得积分10
1秒前
康康星完成签到,获得积分10
2秒前
3秒前
3秒前
去有风的地方完成签到 ,获得积分10
6秒前
上下完成签到 ,获得积分10
8秒前
王娟秀完成签到 ,获得积分10
9秒前
YL完成签到,获得积分10
11秒前
NexusExplorer应助小王采纳,获得10
12秒前
12秒前
sl完成签到,获得积分10
12秒前
CC完成签到,获得积分10
13秒前
自信松思完成签到 ,获得积分10
14秒前
荣枫完成签到,获得积分10
14秒前
14秒前
火火火木完成签到 ,获得积分10
15秒前
大模型应助妖孽宇采纳,获得10
15秒前
17秒前
积极行天发布了新的文献求助50
17秒前
受伤凌蝶发布了新的文献求助10
20秒前
fusucheng完成签到,获得积分10
21秒前
koi完成签到,获得积分20
21秒前
21秒前
聪明摩托完成签到,获得积分10
21秒前
阿纯完成签到,获得积分10
22秒前
23秒前
肱二头肌完成签到,获得积分10
24秒前
25秒前
小王发布了新的文献求助10
25秒前
多情自古空余恨完成签到,获得积分10
26秒前
Qionglin完成签到,获得积分10
28秒前
Bao完成签到 ,获得积分10
29秒前
29秒前
初夏微凉发布了新的文献求助30
29秒前
30秒前
书霂完成签到,获得积分10
30秒前
优秀含羞草完成签到,获得积分10
31秒前
宓沂完成签到,获得积分10
31秒前
vivre223完成签到,获得积分10
31秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038388
求助须知:如何正确求助?哪些是违规求助? 3576106
关于积分的说明 11374447
捐赠科研通 3305798
什么是DOI,文献DOI怎么找? 1819322
邀请新用户注册赠送积分活动 892672
科研通“疑难数据库(出版商)”最低求助积分说明 815029